Pillstats
Rx only · Capsule, Extended Release · Oral

Trospium Chloride

Trospium Chloride

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)236778
US makers8 labelers
Packages17
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.588$1.18$1.76$2.35Dec 2025Apr 2026Jul 2026
$1.760
Latest avg · Jul 22, 2026
-5%
Since Dec 17, 2025
8
Active US suppliers
59%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.9K3.8K5.7K7.6K2025 Q12025 Q22025 Q32025 Q42026 Q1
6.1K
Rx · 2026 Q1
245K
Units dispensed
+5%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it8 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Proficient Rx LPunknown6SUPPLYING
Bryant Ranch Prepackrepackager4SUPPLYING
Granules Pharmaceuticals Incunknown2SUPPLYING
Golden State Medical Supply, Inc.unknown1SUPPLYING
BluePoint Laboratoriesunknown1SUPPLYING
Slate Run Pharmaceuticals, LLCunknown1SUPPLYING
Actavis Pharma, Inc.unknown1SUPPLYING
Padagis US LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Nov 1, 2023
    RECALLRecall (Class II): Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By: Sidmak Laborator…

    Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules — Recalling firm: Padagis US LLC — Nationwide in the USA